Clinical and Inflammatory Profile of COVID-19 Infection at a Tertiary Care Centre in Northern Part of Tamil Nadu - A Retrospective Study.

clinical profile covid-19 inflammatory profile intensive care unit outcome

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Oct 2022
Historique:
accepted: 10 10 2022
entrez: 16 11 2022
pubmed: 17 11 2022
medline: 17 11 2022
Statut: epublish

Résumé

Introduction The coronavirus disease (COVID-19) pandemic has incurred high costs for the entire planet. The complex interactions between the host, virus, and environment have resulted in various clinical outcomes. It is crucial to comprehend sickness severity and outcome predictors to provide early preventative measures for a better outcome. The current study aimed to determine the association of clinical and inflammatory profiles with the outcome of COVID-19 infection in patients admitted to the intensive care unit. Methods This retrospective study was done in patients admitted to intensive care units for COVID-19 with a positive reverse transcriptase polymerase chain reaction (RTPCR) assay. A total of 125 patients above 18 years were included in the study. The patient's age, gender, and co-morbidities like type 2 diabetes mellitus, hypertension, respiratory illness, and coronary artery disease were noted. The patient's symptomatology, vital signs, oxygen saturation (Spo2), need for inotropes, and non-invasive positive pressure ventilator support (NIPPV) were observed. Computed tomography severity score (CTSS) and hematological and inflammatory parameters at the time of admission were noticed. Patient's management and treatment outcomes as survivors and non-survivors were noted. Results The mean age was significantly greater in non-survivors. The common symptoms were fever, respiratory distress, cough, muscle pain, and sore throat. The leucocyte count, C-reactive protein (CRP), urea, creatinine, interleukin-6 (IL-6), and lactate dehydrogenase (LDH) were greater, and platelet counts were lower significantly in the non-survivors group. On multivariable logistic regression, CT severity score, NIPPV, and IL-6 had an odds ratio of 1.17, 0.052, and 1.03, respectively. IL-6 had a sensitivity of 81.5% and a specificity of 81.8% with a cut-off value of 37.5. Conclusion Vigilant monitoring of leucocyte count, CRP, urea, creatinine, IL-6, LDH, platelet count, and CT severity score is essential for managing COVID-19 infection. IL-6 was found to be a significant marker as a predictor of outcome in our study.

Identifiants

pubmed: 36381779
doi: 10.7759/cureus.30139
pmc: PMC9645526
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e30139

Informations de copyright

Copyright © 2022, Shanmukham et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2021 Mar 15;16(3):e0246087
pubmed: 33720944
Ann Hematol. 2020 Jun;99(6):1205-1208
pubmed: 32296910
Clin Transl Imaging. 2022;10(6):663-676
pubmed: 35892066
Front Immunol. 2021 Feb 18;12:613422
pubmed: 33679753
Microbes Infect. 2010 Dec;12(14-15):1120-4
pubmed: 20849976
J Clin Pathol. 2021 Nov;74(11):750-751
pubmed: 33067181
PLoS One. 2020 Aug 25;15(8):e0237302
pubmed: 32841294
BMC Infect Dis. 2020 Jul 16;20(1):519
pubmed: 32677918
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
EClinicalMedicine. 2020 Jul 03;24:100426
pubmed: 32766541
Maedica (Bucur). 2021 Dec;16(4):620-627
pubmed: 35261664
Mayo Clin Proc. 2020 Jun;95(6):1138-1147
pubmed: 32376101
PLoS One. 2020 Dec 28;15(12):e0244171
pubmed: 33370364
BMC Infect Dis. 2021 Jul 8;21(1):663
pubmed: 34238232
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Ann Med. 2021 Dec;53(1):410-412
pubmed: 33305624
Age Ageing. 2021 May 5;50(3):617-630
pubmed: 33543243
Clin Exp Med. 2021 Feb;21(1):35-39
pubmed: 32949308
Am J Hypertens. 2020 Apr 29;33(5):373-374
pubmed: 32251498
IJID Reg. 2022 Mar;2:191-197
pubmed: 35721427
Intervirology. 2020 Dec 9;:1-12
pubmed: 33296901

Auteurs

Bhaskaran Shanmukham (B)

General Medicine, Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research, Melmaruvathur, IND.

Appandraj Srivijayan (A)

General Medicine, Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research, Melmaruvathur, IND.

Sivagamasundari Venugopal (S)

Paediatrics, Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research, Melmaruvathur, IND.

Shyamala Ravikoti (S)

Microbiology, All India Institute of Medical Sciences, Bibinagar, IND.

Ariyanachi Kaliappan (A)

Anatomy, All India Institute of Medical Sciences, Bibinagar, IND.

Archana Gaur (A)

Physiology, All India Institute of Medical Sciences, Bibinagar, IND.

Jeganathan Geetha (J)

General Medicine, Karpaga Vinayaga Institute of Medical Sciences & Research Center, Maduranthagam, IND.

Varatharajan Sakthivadivel (V)

General Medicine, All India Institute of Medical Sciences, Bibinagar, IND.

Yuvaraj Balan (Y)

Biochemistry, All India Institute of Medical Sciences, Bibinagar, IND.

Raja Sundaramurthy (R)

Microbiology, All India Institute of Medical Sciences, Bibinagar, IND.

Classifications MeSH